QLT appoints financial adviser in review of strategic options

By Lisa Kerner

Charlotte, N.C., Dec. 11 - The board of directors of QLT Inc. retained Goldman, Sachs & Co. to assist the company in "identifying, evaluating and pursuing alternative strategies to maximize shareholder value."

The board's special committee will evaluate all opportunities, including transactions involving the sale of all or part of the assets of the company.

"We have chosen Goldman Sachs for this assignment because of its experience in strategic transactions and its in-depth knowledge of the life sciences market," QLT chairman Boyd Clarke said in a company news release.

The Vancouver, B.C.-based biopharmaceutical company does not plan to make additional comments about the review process or its progress.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.